Tobacco Use Disorder
📧 Sign up to get email alerts when something new happens for Tobacco Use Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2015-06-03Clinical Trial Update: Tobacco Treatment Medical Education in 10 Medical Schools [NA]
This is a completed clinical trial updating tobacco treatment education across 10 medical schools; the source does not report study results.
-
CLINICAL_TRIALS trial_result · 2015-05-27Clinical Trial Update: Offering Proactive Tobacco Treatment [NA]
This entry notes the completion of a University of Minnesota-sponsored clinical trial assessing proactive tobacco treatment to support tobac…
-
CLINICAL_TRIALS trial_result · 2015-05-20Clinical Trial Update: Chiropractic Treatment With Counseling Versus Counseling Alone for Promoting Smoking Cessation [Phase 1]
A Phase 1 clinical trial comparing chiropractic treatment with counseling versus counseling alone for promoting smoking cessation was termin…
-
CLINICAL_TRIALS research · 2015-05-14Clinical Trial Update: Motivating Smokers With Mobility Impairments to Quit Smoking [Phase 3]
Phase 3 clinical trial update assessing interventions to help mobility-impaired smokers quit smoking; status is unknown.
-
CLINICAL_TRIALS trial_result · 2015-05-13Clinical Trial Update: Tobacco Cessation Field Study for Adults in Recovery - 1 [Phase 2]
This is a completed Phase 2 tobacco cessation field study in adults in recovery, with an update from sponsor Inflexxion, Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2015-05-04Clinical Trial Update: Novel Psychosocial Influences on Smoking Cessation
A completed clinical trial from Rutgers examined how novel psychosocial factors influence smoking cessation.
-
FDA approval · 2015-04-30FDA Approved: NICOTINE POLACRILEX MINT — Supplemental Application (Walgreens)
FDA approved Walgreens' supplemental application for Nicotine Polacrilex Mint.
-
FDA approval · 2015-04-30FDA Approved: RUGBY NICOTINE POLACRILEX GUM, COATED MINT FLAVOR — Supplemental Application (Rugby Laboratories)
The FDA approved a supplemental application for Rugby Nicotine Polacrilex Gum, Coated Mint Flavor, a nicotine replacement therapy product by…
-
FDA approval · 2015-04-30FDA Approved: NICOTINE — Supplemental Application (P & L Development, LLC)
FDA approved a supplemental application for nicotine polacrilex (nicotine gum) submitted by P & L Development, LLC under ANDA 079038.
-
FDA approval · 2015-04-30FDA Approved: NICOTINE POLACRILEX MINT — Supplemental Application (Walgreens)
The FDA approves a supplemental application for NICOTINE POLACRILEX MINT (nicotine polacrilex lozenge) from Walgreens, expanding the approve…
-
FDA approval · 2015-04-30FDA Approved: RUGBY NICOTINE POLACRILEX GUM, ORIGINAL FLAVOR — Supplemental Application (Rugby Laboratories)
The FDA approved a supplemental application to authorize Rugby Nicotine Polacrilex Gum, Original Flavor, manufactured by Rugby Laboratories,…
-
CLINICAL_TRIALS trial_result · 2015-04-22Clinical Trial Update: An Investigation of Effectiveness and Safety of Varenicline Tartrate in Helping People Quit Smoking [Phase 3]
Phase 3 trial update evaluating the effectiveness and safety of varenicline tartrate for helping people quit smoking; the study has complete…
-
CLINICAL_TRIALS withdrawal · 2015-04-22Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Three Doses of a Controlled Release Formulation of Varenicline for Smoking Cessation [Phase 2]
Phase 2 study evaluating three doses of a controlled-release formulation of varenicline for smoking cessation was withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-04-21Clinical Trial Update: Assessment of V0018 1.5 mg Effect on Craving [Phase 2]
Phase 2 trial evaluating V0018 1.5 mg for craving reduction in tobacco use disorder; the study has completed.
-
CLINICAL_TRIALS trial_result · 2015-04-17Clinical Trial Update: Efficacy of N-Acetyl-Cysteine in Bipolar Disorder and Tobacco Use Disorder [Phase 4]
Phase 4 study evaluating the efficacy of N-acetylcysteine for bipolar disorder and tobacco use disorder. The current registry status is unkn…
-
FDA approval · 2015-04-16FDA Approved: NICORETTE — Supplemental Application (Haleon US Holdings LLC)
FDA approved a supplemental application for NICORETTE (nicotine polacrilex) submitted by Haleon US Holdings LLC.
-
FDA approval · 2015-04-15FDA Approved: GOOD SENSE NICOTINE — Supplemental Application (L. Perrigo Company)
FDA approved a supplemental application for GOOD SENSE NICOTINE (nicotine polacrilex) from L. Perrigo Company.
-
FDA approval · 2015-04-15FDA Approved: EQUATE NICOTINE — Supplemental Application (Wal-Mart Stores Inc)
FDA approved a supplemental application for Equate Nicotine (nicotine polacrilex) from Wal-Mart Stores Inc, a nicotine replacement therapy p…
-
CLINICAL_TRIALS trial_result · 2015-04-10Clinical Trial Update: Support Person Intervention to Promote a Smoking Helpline [NA]
A completed Mayo Clinic clinical trial evaluated whether a support-person intervention can promote use of a smoking helpline to aid tobacco …
-
CLINICAL_TRIALS trial_result · 2015-04-09Clinical Trial Update: Dynamic Assessment and Referral System - Evaluation [Phase 2]
Phase 2 evaluation of a dynamic assessment and referral system for individuals with smoking, alcohol use, or other substance use issues. The…
-
CLINICAL_TRIALS trial_result · 2015-04-07Clinical Trial Update: Smoking Cessation for Young Adults Who Binge Drink - 1 [EARLY_Phase 1]
A completed early-phase trial evaluating nicotine patch use for smoking cessation in young adults who binge drink.
-
CLINICAL_TRIALS research · 2015-04-07Clinical Trial Update: Facilitating Implementation of the PHS Smoking Cessation Guidelines - RESET [NA]
VA-sponsored randomized trial assessing the implementation of the PHS Smoking Cessation Guidelines (RESET) has completed.
-
FDA approval · 2015-04-03FDA Approved: FOSTER AND THRIVE NICOTINE — Supplemental Application (Strategic Sourcing Services LLC)
The FDA approved a supplemental application for Foster and Thrive Nicotine (nicotine polacrilex), a nicotine replacement therapy product, su…
-
CLINICAL_TRIALS trial_result · 2015-04-02Clinical Trial Update: Zileuton With or Without Celecoxib As Chemopreventive Agents in Smokers [Phase 1, Phase 2]
Phase 1/2 trial evaluating zileuton with or without celecoxib as chemopreventive agents in smokers has completed; results were posted in 201…
-
CLINICAL_TRIALS research · 2015-03-26Clinical Trial Update: Intervention Trial of Culturally-Appropriate Decision Aids for Smoking Cessation [NA]
This document reports a clinical trial update on an intervention using culturally appropriate decision aids to support smoking cessation.